Abstract session: HCV Long-term management

 Viral hepatitis

Channel 5
Abstract session
27 August 2020 15:30 - 17:00


Title Time

Add to Calendar

AS151 The dynamics of FIB4 after sustained viral response predicts the risk of liver-related complication in HCV cirrhosis (ANRS CO12 CirVir)
27 August 2020 15:30 - 15:45
AS152 Non-invasive monitoring of liver disease regression in patients with advanced chronic liver disease after sustained virologic response to INF-free therapies
27 August 2020 15:45 - 16:00
AS153 HIV co-infection and risk of morbidity and mortality in HCV patients treated by DAA
27 August 2020 16:00 - 16:15
AS154 Predictive models for hepatocellular carcinoma (HCC) occurrence in patients with chronic hepatitis C and sustained virological response (SVR) achieved with direct acting anti-viral (DAA) included in the ANRS C022 HEPATHER cohort
27 August 2020 16:15 - 16:30
AS155 A simple score for HCC risk stratification in CHC patients with cirrhosis or advanced hepatic fibrosis who achieved SVR following DAA therapy
27 August 2020 16:30 - 16:45
AS156 Virological characterization of patients with chronic hepatitis C and failure to a Glecaprevir/Pibrentasvir or Voxilaprevir/Velpatasvir/Sofosbuvir treatment in the International SHARED collaboration
27 August 2020 16:45 - 17:00